ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q1 2022
The year 2022 has started well. After a weak January, which was burdened by considerable absence in production due to COVID-19, the two last months of the quarter saw strong sales performance. Our brand OrganoTex represents the greatest increase in sales, but several other product groups are also showing double-digit growth. Overall sales for the Group increased by 10.0 (33.3) percent to MSEK 32.6 (29.7).
Translation from CEO Mårten Hellbergs comments to the Interim Report.
Q1, 1 January - 31 March 2022
The Group compared with 2021
» Net revenue amounted to SEK 32.63 (29.66) million
» The gross margin amounted to 25.2 (22.8) %
» EBIT amounted to SEK -4.19 (-4.56) million
» Cash-flow from operating activities amounted to SEK -16.35 (-18.19) million
» Earnings before tax amounted to SEK -4.83 (-5.07) million
The complete version of the Interim Report is attached in this press release and is available on the companys´ homepage. The informationen in this Interim Report is according to the rules of Nasdaq First North Growth Market.
This disclosure contains information that OrganoClick AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 04-05-2022 08:30 CET.